Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Share-based Compensation came in at $52.0 million in Q1 2026, up 20.93% year-on-year from $43.0 million in Q1 2025, and down 38.1% quarter-over-quarter from $84.0 million in Q4 2025.

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Share-based Compensation across 18 years of filings, most recently posting $52.0 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $52.0 million, up 20.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $225.0 million (up 40.62% YoY), and the FY2025 annual result was $216.0 million, up 44.0% from the prior year.
  • Share-based Compensation came in at $52.0 million for Q1 2026 at Bausch Health Companies, down from $84.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q4 2025 to a low of $26.0 million in Q2 2022.
  • The 5-year median for Share-based Compensation is $36.0 million (2024), against an average of $39.8 million.
  • Across the five-year window, Share-based Compensation dropped 19.51% in 2024 and surged 95.35% in 2025, its largest moves.
  • Bausch Health Companies' Share-based Compensation stood at $35.0 million in 2022, then decreased by 17.14% to $29.0 million in 2023, then surged by 48.28% to $43.0 million in 2024, then jumped by 95.35% to $84.0 million in 2025, then tumbled by 38.1% to $52.0 million in 2026.
  • The last three Share-based Compensation figures came in at $52.0 million (Q1 2026), $84.0 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 43.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 25.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 33.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -395,114.54
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 57.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 21.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 36.33 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 36.86 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 16.04 Mn
10 Bausch Health Companies 1.93 Bn 1.59 Bn 2.48 Bn 52.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.00 Mn
Mar 31, 2026 52.00 Mn
Dec 31, 2025 84.00 Mn
Dec 31, 2025 84.00 Mn
Sep 30, 2025 43.00 Mn
Sep 30, 2025 43.00 Mn
Jun 30, 2025 46.00 Mn
Jun 30, 2025 46.00 Mn
Mar 31, 2025 43.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 43.00 Mn
Dec 31, 2024 43.00 Mn
Sep 30, 2024 38.00 Mn
Sep 30, 2024 38.00 Mn
Jun 30, 2024 36.00 Mn
Jun 30, 2024 36.00 Mn
Mar 31, 2024 33.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 29.00 Mn
Dec 31, 2023 29.00 Mn